175 related articles for article (PubMed ID: 15507217)
21. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.
Sandoval V; Riddle EL; Hanson GR; Fleckenstein AE
J Neurosci; 2002 Oct; 22(19):8705-10. PubMed ID: 12351745
[TBL] [Abstract][Full Text] [Related]
22. Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals.
Nirenberg MJ; Chan J; Liu Y; Edwards RH; Pickel VM
Synapse; 1997 Jun; 26(2):194-8. PubMed ID: 9131778
[TBL] [Abstract][Full Text] [Related]
23. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
[TBL] [Abstract][Full Text] [Related]
24. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
[TBL] [Abstract][Full Text] [Related]
25. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry.
Volz TJ; Hanson GR; Fleckenstein AE
J Neurosci Methods; 2006 Jul; 155(1):109-15. PubMed ID: 16480775
[TBL] [Abstract][Full Text] [Related]
26. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
27. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice.
Akhisaroglu M; Kurtuncu M; Manev H; Uz T
Pharmacol Biochem Behav; 2005 Mar; 80(3):371-7. PubMed ID: 15740778
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases.
Wang C; Buck DC; Yang R; Macey TA; Neve KA
J Neurochem; 2005 May; 93(4):899-909. PubMed ID: 15857393
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Brocco M; Dekeyne A; Papp M; Millan MJ
Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
[TBL] [Abstract][Full Text] [Related]
30. The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter.
Lee ES; Chen H; Shepherd KR; Lamango NS; Soliman KF; Charlton CG
Neurosci Res; 2004 Mar; 48(3):335-44. PubMed ID: 15154679
[TBL] [Abstract][Full Text] [Related]
31. Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen.
Mignini F; Tomassoni D; Traini E; Amenta F
J Neuroimmunol; 2009 Jan; 206(1-2):5-13. PubMed ID: 19012970
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus.
Fumagalli F; Bedogni F; Maragnoli ME; Gennarelli M; Perez J; Racagni G; Riva MA
J Neurosci Res; 2003 Oct; 74(1):74-80. PubMed ID: 13130508
[TBL] [Abstract][Full Text] [Related]
33. D2 autoreceptors are not involved in the down-regulation of the striatal dopamine transporter caused by alpha-methyl-p-tyrosine.
Han S; Rowell PP; Carr LA
Res Commun Mol Pathol Pharmacol; 1999; 104(3):331-8. PubMed ID: 10741383
[TBL] [Abstract][Full Text] [Related]
34. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.
Vander Borght T; Kilbourn M; Desmond T; Kuhl D; Frey K
Eur J Pharmacol; 1995 Dec; 294(2-3):577-83. PubMed ID: 8750721
[TBL] [Abstract][Full Text] [Related]
35. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
36. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
Kilbourn MR; Sherman PS; Kuszpit K
Synapse; 2002 Mar; 43(3):188-94. PubMed ID: 11793424
[TBL] [Abstract][Full Text] [Related]
37. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
Ramanathan S; Tkatch T; Atherton JF; Wilson CJ; Bevan MD
J Neurophysiol; 2008 Feb; 99(2):442-59. PubMed ID: 18094105
[TBL] [Abstract][Full Text] [Related]
38. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.
Riddle EL; Topham MK; Haycock JW; Hanson GR; Fleckenstein AE
Eur J Pharmacol; 2002 Aug; 449(1-2):71-4. PubMed ID: 12163108
[TBL] [Abstract][Full Text] [Related]
39. Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications.
Hanson GR; Sandoval V; Riddle E; Fleckenstein AE
Ann N Y Acad Sci; 2004 Oct; 1025():146-50. PubMed ID: 15542712
[TBL] [Abstract][Full Text] [Related]
40. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
